Interferon in the treatment of base of the skull hemangioendothelioma.
Freeman
A I
AI
Department of Oncology, Hadassah University Hospital, Jerusalem, Israel.
Lossos
A
A
Gomori
J M
JM
Schwartz
A
A
Elidan
J
J
Siegal
T
T
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002675:Child, Preschool; D006390:Hemangioendothelioma / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008297:Male; D011994:Recombinant Proteins; D019292:Skull Base Neoplasms / Q000175:diagnosis / Q000188:drug therapy*
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins